- Normal range of serum ALT level in patients with chronic hepatitis
-
Seo YS
- KMID: 1073338
- Korean J Hepatol.
- 2008 Mar;14(1):116-121.
- doi: 10.3350/kjhep.2008.14.1.116
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Angiomyolipoma
-
Lee WJ
- KMID: 1073337
- Korean J Hepatol.
- 2008 Mar;14(1):113-115.
- doi: 10.3350/kjhep.2008.14.1.113
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatic adenomatosis in glycogen storage disease
-
Kwon JE, Park YN
- KMID: 1073336
- Korean J Hepatol.
- 2008 Mar;14(1):108-112.
- doi: 10.3350/kjhep.2008.14.1.108
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease
-
Kim MY, Baik SK
- KMID: 1073324
- Korean J Hepatol.
- 2008 Mar;14(1):1-3.
- doi: 10.3350/kjhep.2008.14.1.1
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Recent developments in systemic chemotherapy for hepatocellular carcinoma
-
Han CJ
- KMID: 1073325
- Korean J Hepatol.
- 2008 Mar;14(1):4-11.
- doi: 10.3350/kjhep.2008.14.1.4
Despite recent developments in various chemotherapeutic agents and the performing of numerous clinical trials, chemotherapy still produces unsatisfactory results in hepatocellular carcinoma due to poor clinical benefit compared with untreated... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of ticlopidine induced acute cholestatic hepatitis and pure red cell aplasia
-
Lee JY, Park EB, Ahn JH, Suh SJ, Jung YK, Kim JH, Shin BK, Yang JH, Yeon JE, Byun KS
- KMID: 1073335
- Korean J Hepatol.
- 2008 Mar;14(1):102-107.
- doi: 10.3350/kjhep.2008.14.1.102
Ticlopidine inhibits platelet aggregation and provides beneficial secondary prevention of cerebrovascular and coronary artery disease. Frequently reported adverse effects of ticlopidine include diarrhea, nausea, and rash. However, to our knowledge,... -
- CITED
-
- Close
- SHARE
-
- Close
- Nonalcoholic steatohepatitis: Pathogenesis and treatment
-
Park SH
- KMID: 1073326
- Korean J Hepatol.
- 2008 Mar;14(1):12-27.
- doi: 10.3350/kjhep.2008.14.1.12
Nonalcoholic fatty liver disease (NAFLD) is characterized by a wide spectrum of liver damage spanning steatosis, nonalcoholic steatohepatitis (NASH), cryptogenic liver cirrhosis, and even to hepatocellular carcinoma. Investigations in the... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatic myelopathy as a presenting neurological complication in patients with cirrhosis and spontaneous splenorenal shunt
-
Koo JE, Lim YS, Myung SJ, Suh KS, Kim KM, Lee HC, Chung YH, Lee YS, Suh DJ
- KMID: 1073333
- Korean J Hepatol.
- 2008 Mar;14(1):89-96.
- doi: 10.3350/kjhep.2008.14.1.89
Hepatic myelopathy is a rare complication of chronic liver disease that is associated with extensive portosystemic shunts. The main clinical feature of hepatic myelopathy is progressive spastic paraparesis in the... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of allopurinol-induced granulomatous hepatitis with ductopenia and cholestasis
-
Yoon JY, Min SY, Park JY, Hong SG, Park SJ, Paik SY, Park YM
- KMID: 1073334
- Korean J Hepatol.
- 2008 Mar;14(1):97-101.
- doi: 10.3350/kjhep.2008.14.1.97
Allopurinol-induced hypersensitivity syndrome is characterized by an idiosyncratic reaction involving multiple-organs, which usually begins 2 to 6 weeks after starting allopurinol. In rare cases, the adverse reactions to allopurinol are... -
- CITED
-
- Close
- SHARE
-
- Close
- Distribution of hepatitis C virus genotypes in Jeju Island
-
Lee H, Cho YK, Kim HU, Choi EK, Hyun S, Kang D, Jeong SU, Kim HJ, Kim KS, Song BC
- KMID: 1073327
- Korean J Hepatol.
- 2008 Mar;14(1):28-35.
- doi: 10.3350/kjhep.2008.14.1.28
BACKGROUNDS/AIMS: The hepatitis C virus (HCV) genotype affects clinical outcomes of HCV infection, in terms of the response to antiviral therapy and progression of chronic liver diseases, and shows... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of therapeutic results between combination therapy of peginterferon alpha-2a plus ribavirin and interferon alpha-2b plus ribavirin according to treatment duration in patients with chronic hepatitis C
-
Lee HJ, Eun JR, Choi JW, Kim KO, Moon HJ
- KMID: 1073329
- Korean J Hepatol.
- 2008 Mar;14(1):46-57.
- doi: 10.3350/kjhep.2008.14.1.46
BACKGROUND/AIMS: This study compared the efficacy and safety of combined peginterferon alfa (PEG-IFN) and ribavirin with that of combined interferon alpha (IFN-alpha) and ribavirin, according to the treatment duration... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C
-
Kim KT, Han SY, Kim JH, Yoon HA, Baek YH, Kim MJ, Lee SW, Jang JS, Lee JH, Roh MH
- KMID: 1073328
- Korean J Hepatol.
- 2008 Mar;14(1):36-45.
- doi: 10.3350/kjhep.2008.14.1.36
BACKGROUND/AIMS: The purpose of this study is to elucidate the efficacy and safety of combined peginterferon and ribavirin therapy in Korean patients with chronic HCV infection. METHODS: We... -
- CITED
-
- Close
- SHARE
-
- Close
- Factors affecting initial virologic response and emergence of resistant mutants after adefovir treatment in lamivudine-resistant chronic hepatitis B patients
-
Cho JH, Cheong JY, Kang JK, Park JS, Lee MH, Lim NK, Hong SP, Kim SO, Yoo WD, Cho SW
- KMID: 1073330
- Korean J Hepatol.
- 2008 Mar;14(1):58-66.
- doi: 10.3350/kjhep.2008.14.1.58
BACKGROUND/AIMS: Adefovir dipivoxil (adefovir) effectively inhibits both wild-type and lamivudine-resistant hepatitis B virus (HBV) replication. The development of adefovir resistance is both delayed and infrequent compared with lamivudine resistance.... -
- CITED
-
- Close
- SHARE
-
- Close
- The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis
-
Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH
- KMID: 1073331
- Korean J Hepatol.
- 2008 Mar;14(1):67-76.
- doi: 10.3350/kjhep.2008.14.1.67
BACKGROUND/AIMS: Alcohol and the hepatitis B virus (HBV) exert synergistic effects in hepatocelluar carcinogenesis. We aimed to elucidate the clinical significance of the antibody to hepatitis B core antigen... -
- CITED
-
- Close
- SHARE
-
- Close
- Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease; Relation of non-alcoholic fatty liver disease to carotid atherosclerosis
-
Choi SY, Kim D, Kang JH, Park MJ, Kim YS, Lim SH, Kim CH, Lee HS
- KMID: 1073332
- Korean J Hepatol.
- 2008 Mar;14(1):77-88.
- doi: 10.3350/kjhep.2008.14.1.77
BACKGROUND/AIMS: Non-alcoholic fatty liver disease (NAFLD) is closely associated with abdominal obesity, dyslipidemia, hypertension, and Type 2 diabetes, which are all features of the metabolic syndrome. The aim of... -
- CITED
-
- Close
- SHARE
-
- Close
